Theravance Biopharma (NASDAQ: TBPH) has announced the launch of Power in the Periphery—a new disease education campaign to raise awareness and deepen scientific understanding of the pathophysiology underlying neurogenic orthostatic hypotension (nOH) associated with multiple system atrophy (MSA).
The company introduced the initiative at the International Congress of Parkinson’s Disease and Movement Disorders (MDS), held in Honolulu, Hawaii, October 5–9, 2025.
In a statement, Rick E Winningham, CEO of Theravance, commented, “The Power in the Periphery campaign underscores our ongoing commitment to advancing education for healthcare professionals about the complex mechanisms underlying nOH. Through this initiative, we aim to deepen scientific understanding of nOH, particularly in the context of MSA, and foster meaningful engagement with clinicians on this challenging condition.”
